litlas
Log inCreate account

Bryan T. Hennessy

Active 2004–2025

101
Papers
29,021
Citations
71
h-index
100
i10-index

Citations

Citations per year for Bryan T. Hennessy1945: 2 citations1982: 1 citations2004: 2 citations2005: 8 citations2006: 30 citations2007: 77 citations2008: 154 citations2009: 270 citations2010: 361 citations2011: 409 citations2012: 458 citations2013: 440 citations2014: 506 citations2015: 467 citations2016: 403 citations2017: 407 citations2018: 362 citations2019: 1,055 citations2020: 1,050 citations2021: 1,034 citations2022: 767 citations2023: 523 citations2024: 747 citations2025: 344 citations2026: 6 citations1946–1981: no citations, so these years are not shown1983–2003: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,846 citing papers, 28% of this breakdownChina: 1,679 citing papers, 12.2% of this breakdownUnited Kingdom: 869 citing papers, 6.3% of this breakdownItaly: 665 citing papers, 4.8% of this breakdownGermany: 544 citing papers, 4% of this breakdownCanada: 535 citing papers, 3.9% of this breakdownFrance: 450 citing papers, 3.3% of this breakdownSpain: 389 citing papers, 2.8% of this breakdownAustralia: 353 citing papers, 2.6% of this breakdownJapan: 325 citing papers, 2.4% of this breakdownSouth Korea: 301 citing papers, 2.2% of this breakdownIndia: 290 citing papers, 2.1% of this breakdown
0%28%Other 25.4%

Institutions

Fields

  • Biochemistry, Genetics and Molecular Biology47.5%
  • Medicine44.8%
  • Immunology and Microbiology1.8%
  • Computer Science1.6%
  • Neuroscience0.8%
  • Engineering0.7%
  • Other2.8%

Topics

  • Breast Cancer Treatment Studies5.1%
  • PI3K/AKT/mTOR signaling in cancer3.9%
  • HER2/EGFR in Cancer Research3.6%
  • PARP inhibition in cancer therapy3.2%
  • Cancer Cells and Metastasis3.1%
  • Cancer Genomics and Diagnostics3%
  • Other78.1%

Coauthors

All papers

Open in search
  1. Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer

    Authors: Cornelia Liedtke, Chafika Mazouni, Kenneth R. Hess, Fabrice André, Attila Tordai, Jaime Mejia, W. Fraser Symmans, Ana M. González-Angulo, Bryan T. Hennessy, Marjorie Green, Massimo Cristofanilli, Gabriel N. Hortobágyi, Lajos Pusztai - Journal of Clinical Oncology 2008 cited by 2,906

  2. Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer

    Authors: Melinda L. Telli, Kirsten M. Timms, Julia Reid, Bryan T. Hennessy, Gordon B. Mills, Kristin C. Jensen, Zoltán Szállási, William T. Barry, Eric P. Winer, Nadine Tung, Steven J. Isakoff, Paula D. Ryan, April Greene-Colozzi, Alexander Gutin, Zaina Sangale, Diana Iliev, Chris Neff, Victor Abkevich, Joshua T. Jones, Jerry S. Lanchbury, Anne‐Renee Hartman, Judy E. Garber, James M. Ford, Daniel P. Silver, Andrea L. Richardson - Clinical Cancer Research 2016 cited by 1,163

  3. Measurement of Residual Breast Cancer Burden to Predict Survival After Neoadjuvant Chemotherapy

    Authors: W. Fraser Symmans, Florentia Peintinger, Christos Hatzis, Radhika Rajan, Henry M. Kuerer, Vicente Valero, Lina Assad, Anna W. Poniecka, Bryan T. Hennessy, Marjorie Green, Aman U. Buzdar, S. Eva Singletary, Gabriel N. Hortobágyi, Lajos Pusztai - Journal of Clinical Oncology 2007 cited by 1,662

  4. Exploiting the PI3K/AKT Pathway for Cancer Drug Discovery

    Authors: Bryan T. Hennessy, Debra L. Smith, Prahlad T. Ram, Yiling Lu, Gordon B. Mills - Nature Reviews Drug Discovery 2005 cited by 2,163

  5. Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer

    Authors: Victor Abkevich, Kirsten M. Timms, Bryan T. Hennessy, Jennifer Potter, Mark Carey, Lisa Meyer, Karen Smith‐McCune, Russell Broaddus, K.H. Lu, J Chen, Thuan Van Tran, Deniece R. Williams, Diana Iliev, Srikanth Jammulapati, Liesel M. FitzGerald, Thomas C. Krivak, Julie A. DeLoia, Alexander Gutin, Gordon B. Mills, J. S. Lanchbury - British Journal of Cancer 2012 cited by 852

  6. An Integrative Genomic and Proteomic Analysis of PIK3CA, PTEN, and AKT Mutations in Breast Cancer

    Authors: Katherine Stemke‐Hale, Ana M. González-Angulo, Aňa Lluch, Richard M. Neve, Wen-Lin Kuo, Michael A. Davies, Mark Carey, Zhi Hu, Yinghui Guan, Ayşegül A. Şahin, W. Fraser Symmans, Lajos Pusztai, Laura K. Nolden, Hugo M. Horlings, Katrien Berns, Mien‐Chie Hung, Marc J. van de Vijver, Vicente Valero, Joe W. Gray, René Bernards, Gordon B. Mills, Bryan T. Hennessy - Cancer Research 2008 cited by 1,043

  7. A Functional Genetic Approach Identifies the PI3K Pathway as a Major Determinant of Trastuzumab Resistance in Breast Cancer

    Authors: Katrien Berns, Hugo M. Horlings, Bryan T. Hennessy, Mandy Madiredjo, E. Marielle Hijmans, Karin Beelen, Sabine C. Linn, Ana M. González-Angulo, Katherine Stemke‐Hale, Michael Hauptmann, Roderick L. Beijersbergen, Gordon B. Mills, Marc J. van de Vijver, René Bernards - Cancer Cell 2007 cited by 1,623

  8. Ponesimod Compared With Teriflunomide in Patients With Relapsing Multiple Sclerosis in the Active-Comparator Phase 3 OPTIMUM Study

    Authors: Ludwig Kappos, Robert J. Fox, Michel Burcklen, Mark S. Freedman, Eva Havrdová, Bryan T. Hennessy, Reinhard Hohlfeld, Fred Lublin, Xavier Montalbán, Carlo Pozzilli, Tatiana Scherz, Daniele D’Ambrosio, Philippe Linscheid, Andrea Vaclavkova, Magdalena Pirozek-Lawniczek, Hilke Kracker, Till Sprenger - JAMA Neurology 2021 cited by 218

  9. Hyperactivation of phosphatidylinositol-3 kinase promotes escape from hormone dependence in estrogen receptor–positive human breast cancer

    Authors: Todd W. Miller, Bryan T. Hennessy, Ana M. González-Angulo, Emily M. Fox, Gordon B. Mills, Heidi Chen, Catherine Higham, Carlos Garcı́a-Echeverrı́a, Yu Shyr, Carlos L. Arteaga - Journal of Clinical Investigation 2010 cited by 545

  10. The biology of ovarian cancer: new opportunities for translation

    Authors: Robert C. Bast, Bryan T. Hennessy, Gordon B. Mills - Nature reviews. Cancer 2009 cited by 1,370

  11. The energy sensing LKB1–AMPK pathway regulates p27kip1 phosphorylation mediating the decision to enter autophagy or apoptosis

    Authors: Jiyong Liang, Shan Shao, Zhixiang Xu, Bryan T. Hennessy, Zhiyong Ding, Michelle D. Larrea, Seiji Kondo, Dan Dumont, Jordan U. Gutterman, Cheryl L. Walker, Joyce M. Slingerland, Gordon B. Mills - Nature Cell Biology 2007 cited by 851

  12. Correlating transcriptional networks to breast cancer survival: a large-scale coexpression analysis

    Authors: Colin Clarke, Stephen F. Madden, Padraig Doolan, Sinéad Aherne, Helena Joyce, Lorraine O’Driscoll, William M. Gallagher, Bryan T. Hennessy, M. Moriarty, John Crown, Susan Kennedy, Martin Clynes - Carcinogenesis 2013 cited by 877

  13. Ovarian cancer

    Authors: Bryan T. Hennessy, Robert L. Coleman, Maurie Markman - The Lancet 2009 cited by 652

  14. Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer

    Authors: Suzanne A. Eccles, Eric O. Aboagye, Simak Ali, Annie S. Anderson, Jo Armes, Fedor Berditchevski, Jeremy P. Blaydes, Keith Brennan, Nicola J. Brown, Helen E. Bryant, Nigel Bundred, Joy Burchell, Anna Campbell, Jason S. Carroll, Robert B. Clarke, Charlotte E. Coles, Gary Cook, Angela Cox, Nicola J. Curtin, Lodewijk V. Dekker, Isabel dos‐Santos‐Silva, Stephen W. Duffy, Douglas F. Easton, Diana M Eccles, Dylan R. Edwards, Joanne Edwards, D. Gareth Evans, Deborah Fenlon, James M. Flanagan, Claire Foster, William M. Gallagher, Montserrat García‐Closas, Julia M.W. Gee, Andy J Gescher, Vicky Goh, Ashley M. Groves, Amanda Harvey, Michelle Harvie, Bryan T. Hennessy, Stephen Hiscox, Ingunn Holen, Sacha J. Howell, Anthony Howell, Gill Hubbard, Nick Hulbert-Williams, Myra S. Hunter, Bharat Jasani, J. Louise Jones, Timothy J. Key, Cliona Kirwan, Anthony Kong, Ian Kunkler, Simon P. Langdon, Martin O. Leach, David J. Mann, John F. Marshall, Lesley Martin, Stewart G. Martin, J Macdougall, David Miles, William R. Miller, Joanna R. Morris, Sue Moss, Paul B. Mullan, Rachael Natrajan, James P.B. O’Connor, Rosemary O’Connor, Carlo Palmieri, Paul D.P. Pharoah, Emad A. Rakha, Elizabeth Reed, Simon P. Robinson, Erik Sahai, John Saxton, Peter Schmid, Matthew J. Smalley, Valerie Speirs, Robert C. Stein, Julia Stingl, Charles Streuli, Andrew Tutt, Galina Velikova, Rosemary A. Walker, Christine J. Watson, Kaye J. Williams, Leonie S. Young, Alastair M. Thompson - Breast Cancer Research 2013 cited by 426

  15. Tumor PIK3CA Genotype and Prognosis in Early-Stage Breast Cancer: A Pooled Analysis of Individual Patient Data

    Authors: Dimitrios Zardavas, Luc te Marvelde, Roger L. Milne, Debora Fumagalli, George Fountzilas, Vassiliki Kotoula, Evangelia Razis, George Papaxoinis, Heikki Joensuu, Mary Ellen Moynahan, Bryan T. Hennessy, Ivan Bièche, Lao H. Saal, Olle Stål, Barry Iacopetta, Jeanette Dupont Jensen, Sandra A. O’Toole, Elena López‐Knowles, Mattia Barbaraeschi, Shinzaburo Noguchi, Hatem A. Azim, Enrique Lerma, Thomas Bachelot, Qing Wang, Gizeh Pérez‐Tenorio, Cornelis J.H. can de Velde, Daniel Rea, Vicky S. Sabine, John M.S. Bartlett, Christos Sotiriou, Stefan Michiels, Sherene Loi - Journal of Clinical Oncology 2018 cited by 147

  16. Characterization of a Naturally Occurring Breast Cancer Subset Enriched in Epithelial-to-Mesenchymal Transition and Stem Cell Characteristics

    Authors: Bryan T. Hennessy, Ana-Maria Gonzalez-Angulo, Katherine Stemke‐Hale, Michael Z. Gilcrease, Savitri Krishnamurthy, Ju‐Seog Lee, Jane Fridlyand, Ayşegül A. Şahin, Roshan Agarwal, Corwin Joy, Wenbin Liu, David Stivers, Keith Baggerly, Mark Carey, Aňa Lluch, Carlos Monteagudo, Xiaping He, Victor Weigman, Cheng Fan, Juan Palazzo, Gabriel N. Hortobágyi, Laura K. Nolden, Nicholas J. Wang, Vicente Valero, Joe W. Gray, Charles M. Perou, Gordon B. Mills - Cancer Research 2009 cited by 857

  17. High Frequency of PIK3R1 and PIK3R2 Mutations in Endometrial Cancer Elucidates a Novel Mechanism for Regulation of PTEN Protein Stability

    Authors: Lydia W.T. Cheung, Bryan T. Hennessy, Jie Li, Shuangxing Yu, Andrea P. Myers, Bojana Djordjevic, Yiling Lu, Katherine Stemke‐Hale, Mary D. Dyer, Fan Zhang, Zhenlin Ju, Lewis C. Cantley, Steven E. Scherer, Han Liang, Karen H. Lu, Russell R. Broaddus, Gordon B. Mills - Cancer Discovery 2011 cited by 472

  18. Genome-wide transcriptome profiling of homologous recombination DNA repair

    Authors: Guang Peng, Curtis Chun-Jen Lin, Wei Mo, Hui Dai, Yun‐Yong Park, Soo Mi Kim, Yang Peng, Qianxing Mo, Stefan Siwko, Ruozhen Hu, Ju‐Seog Lee, Bryan T. Hennessy, Samir Hanash, Gordon B. Mills, Shiaw‐Yih Lin - Nature Communications 2014 cited by 228

  19. Survival with Trastuzumab Emtansine in Residual HER2-Positive Breast Cancer

    Authors: Charles E. Geyer, M. Untch, Chiun‐Sheng Huang, Max S. Mano, Eleftherios P. Mamounas, Norman Wolmark, Priya Rastogi, Andreas Schneeweiß, Andrés Redondo, Hans Holger Fischer, Véronique D’Hondt, Alison Conlin, Valentina Guarneri, Irene Wapnir, Christian Jackisch, Claudia Arce-Salinas, Peter A. Fasching, Michael P. DiGiovanna, John Crown, Pia Wuelfing, Zhimin Shao, Elena Rota Caremoli, Hervé Bonnefoi, Bryan T. Hennessy, Ljiljana Stamatović, Hugo Castro‐Salguero, Adam Brufsky, Adam Knott, Asna Siddiqui, Chiara Lambertini, Thomas Boulet, Beatrice Nyawira, Eleonora Restuccia, Sibylle Loibl - New England Journal of Medicine 2025 cited by 115

  20. Effects of HER Family–targeting Tyrosine Kinase Inhibitors on Antibody-dependent Cell-mediated Cytotoxicity in HER2-expressing Breast Cancer

    Authors: Denis M. Collins, Stephen F. Madden, Nicola Gaynor, Dalal AlSultan, Marion Le Gal, Alex J. Eustace, Kathy Gately, Clare Hughes, Anthony M. Davies, Thamir Mahgoub, Jo Ballot, Sinéad Toomey, Darran P. O’Connor, William M. Gallagher, Frankie A. Holmes, Virginia Espina, Lance A. Liotta, Bryan T. Hennessy, Kenneth J. O’Byrne, Max Hasmann, Birgit Bossenmaier, Norma O’Donovan, John Crown - Clinical Cancer Research 2020 cited by 76

  21. Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells

    Authors: Raoul Tibes, Yihua Qiu, Yiling Lu, Bryan T. Hennessy, Michael Andreeff, Gordon B. Mills, Steven M. Kornblau - Molecular Cancer Therapeutics 2006 cited by 758

  22. Subtype and pathway specific responses to anticancer compounds in breast cancer

    Authors: Laura M. Heiser, Anguraj Sadanandam, Wen‐Lin Kuo, Stephen C. Benz, Theodore C. Goldstein, Sam Ng, William J. Gibb, Nicholas J. Wang, Safiyyah Ziyad, Frances Tong, Nora Bayani, Zhi Hu, Jessica I. Billig, Andrea Dueregger, Sophia Lewis, Lakshmi R. Jakkula, James E. Korkola, Steffen Durinck, François Pépin, Yinghui Guan, Elizabeth Purdom, Pierre Neuvial, Henrik Bengtsson, Kenneth W. Wood, Peter G. Smith, Lyubomir T. Vassilev, Bryan T. Hennessy, Joel Greshock, Kurtis E. Bachman, Mary Ann Hardwicke, John W. Park, Laurence J. Marton, Denise M. Wolf, Eric A. Collisson, Richard M. Neve, Gordon B. Mills, Terence P. Speed, Heidi S. Feiler, Richard Wooster, David Haussler, Joshua M. Stuart, Joe W. Gray, Paul T. Spellman - National Academy of Sciences, Proceedings of the National Academy of Sciences 2011 cited by 504

  23. Outcome After Pathologic Complete Eradication of Cytologically Proven Breast Cancer Axillary Node Metastases Following Primary Chemotherapy

    Authors: Bryan T. Hennessy, Gabriel N. Hortobágyi, Roman Rouzier, Henry M. Kuerer, Nour Sneige, Aman U. Buzdar, Shu Wan Kau, Bruno D. Fornage, Ayşegül A. Şahin, Kristine Broglio, S. Eva Singletary, Vicente Valero - Journal of Clinical Oncology 2005 cited by 422

  24. Adipose tissue derived stem cells differentiate into carcinoma-associated fibroblast-like cells under the influence of tumor derived factors.

    Authors: Constantin Jotzu, Eckhard Alt, Gabriel Welte, Jie Li, Bryan T. Hennessy, Eswaran Devarajan, Srinivasalu Krishnappa, Severin Pinilla, Lilly Droll, Yao‐Hua Song - Analytical Cellular Pathology 2010 cited by 236